Microarray-based classifiers and prognosis models identify subgroups with distinct clinical outcomes and high risk of AML transformation of myelodysplastic syndrome

1. Mills, K.I.
2. Kohlmann, A.
3. Williams, P.M.
4. Wieczorek, L.
5. Liu, W.-M.
6. Li, R.
7. Wei, W.
8. Bowen, D.T.
9. Loeffler, H.
10. Hernandez, J.M.
11. Hofmann, W.-K.
12. Haferlach, T.